LEADER 01246nam a2200337 i 4500 001 991000646329707536 005 20020507171716.0 008 941207s1981 us ||| | eng 020 $a082476949X 035 $ab10737492-39ule_inst 035 $aLE01300104$9ExL 040 $aDip.to Matematica$beng 082 0 $a515 084 $aAMS 26-01 084 $aAMS 26-XX 084 $aLC QA303.V68 100 1 $aVoxman, William L.$055550 245 10$aAdvanced calculus :$ban introduction to modern analysis /$cWilliam L. Voxman, Roy H. Goetschel, jr 260 $aNew York ; Basel :$bMarcel Dekker,$cc1981 300 $axii, 678 p. ;$c24 cm 490 0 $aPure and applied mathematics.$pA series of monographs & textbooks, [Marcel Dekker]$x0079-8169 ;$v63 500 $aIncludes bibliographical referencces and index 650 0$aReal functions 650 0$aReal functions-textbooks 700 1 $aGoetschel, Roy H. 907 $a.b10737492$b23-02-17$c28-06-02 912 $a991000646329707536 945 $aLE013 26-XX VOX11 (1981)$g1$i2013000027234$lle013$o-$pE0.00$q-$rl$s- $t0$u4$v0$w4$x0$y.i10827717$z28-06-02 996 $aAdvanced calculus$9911080 997 $aUNISALENTO 998 $ale013$b01-01-94$cm$da $e-$feng$gus $h0$i1 LEADER 02536oam 22005414a 450 001 9910696457603321 005 20230905163625.0 035 $a(CKB)5470000002378265 035 $a(OCoLC)57682710 035 $a(EXLCZ)995470000002378265 100 $a20030204d2002 ua 0 101 0 $aeng 135 $aurcn||||||||| 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 10$aPrescription drug therapies$b[electronic resource] $ereducing costs and improving outcomes /$fauthors, Barbara L. Kass-Bartlemes, Lynn Bosco 210 1$aRockville, Md. :$cAgency for Healthcare Research and Quality,$d[2002] 215 $a11 pages $cdigital, PDF file 225 1 $aResearch in action ;$vissue #8 225 1 $aAHRQ pub. ;$vno. 02-0045 300 $aTitle from PDF caption (viewed Mar. 6, 2008). 300 $a"September 2002." 320 $aIncludes bibliographical references. 330 $aThe report describes Agency for Healthcare Research and Quality (AHRQ) funded research that helps to answer questions about prescription medicine. AHRQ research has identified conditions for which drug therapy is not necessary. It has discovered low-cost drug therapies that provide patients with the same quality of care as more expensive drugs. It has also revealed that sometimes the newest, most expensive drug therapy reduces costs overall because it keeps patients healthier and less likely to use other health care services. AHRQ has also finded research thatb investigated the cost effectiveness and safety of outpatient vs. inpatient services and the impact of preventive drug therapy. 517 $aPrescription drug therapies 606 $aPrescription pricing$zUnited States$xCosts 606 $aChemotherapy$xEconomic aspects$zUnited States 606 $aPrescription Drugs$xeconomics 606 $aDrug Therapy$xeconomics 606 $aDrug Therapy$xmethods 607 $aUnited States 615 0$aPrescription pricing$xCosts. 615 0$aChemotherapy$xEconomic aspects 615 12$aPrescription Drugs$xeconomics. 615 22$aDrug Therapy$xeconomics. 615 22$aDrug Therapy$xmethods. 700 $aKass-Bartelmes$b Barbara L$01388061 701 $aBosco$b Lynn$01420956 712 02$aUnited States.$bAgency for Healthcare Research and Quality. 801 0$bNLM 801 1$bNLM 801 2$bOCLCQ 801 2$bGPO 906 $aBOOK 912 $a9910696457603321 996 $aPrescription drug therapies$93540584 997 $aUNINA